ArticleFrontiers in oncology2021
Risk Stratification for Organ/Space Surgical Site Infection in Advanced Digestive System Cancer.
Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02715076 (The Effects of Ambient Temperature and Forced-air Warming on Intraoperative Core Temperature), which is not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
The Effects of Ambient Temperature and Forced-air Warming on Intraoperative Core Temperature
Who cites it
9 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Systematic review of risk prediction models for surgical site infection after abdominal surgery in adults.Frontiers in public health · 2026Pooled it
- Risk prediction model for surgical site infection in patients with gastrointestinal cancer: a systematic review and meta-analysis.World journal of surgical oncology · 2025Pooled it
- Risks and outcomes of surgical site infection after minimally invasive colorectal surgery: a Japanese multicenter study.Surgery today · 2026Observational
- Development and validation of a predictive model for surgical site infection following joint surgery.Annals of joint · 2025Article
- Risk prediction models for postoperative intra-abdominal infection in patients with digestive system tumors: a systematic review.Frontiers in oncology · 2025Review
- Comparison of olanexidine versus povidone-iodine as a preoperative antiseptic for reducing surgical site infection in both scheduled and emergency gastrointestinal surgeries: A single-center randomized clinical trial.Annals of gastroenterological surgery · 2023Article
- Impact of Perioperative Prophylaxis WithTransplantation direct · 2023Article
- Surgical Site Infection in Cardiac Surgery.Journal of clinical medicine · 2022Review
- RoboticIn vivo (Athens, Greece)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOrgan/space surgical site infection (organ/space SSI) is a serious postoperative complication, closely related to a poor prognosis. Few studies have attempted to stratify the risk of organ/space SSI for patients with advanced digestive system cancer. This study aimed to identify a simple risk stratification for these patients based on perioperative factors.
methodsThe study was based on two randomized controlled trials (RCT) (NCT02715076, ChiCTR-IPR-17011099), including 839 patients undergoing elective radical resection of advanced digestive system cancer. The primary outcome was organ/space SSI within 30 days after surgery. Multivariable logistic regression model was used to identify risk factors. The risk of organ/space SSI stratified over those risk factors was compared using chi-square tests and the relative risk (RR) was estimated.
resultsAmong the 839 patients, 51 developed organ/space SSI (6.1%) within 30 days after surgery. According to the multivariable logistic regression model, 3 procedure types, including gastrectomy (OR=8.22, 95% CI: 2.71-24.87,
conclusionThis study is a preliminary exploratory and provides a simple risk stratification to identify the risk of postoperative organ/space SSI for patients with advanced digestive system cancer. Further research is needed to validate and generalize the results in a wider population. CLINICAL
trial registrationClinicalTrials.gov, identifier NCT02715076; Chinese Clinical Trial Registry [https://www.chictr.org.cn/enindex.aspx], identifier ChiCTR-IPR-17011099.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.